Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab
Clinical trial NCT05877859 · RECRUITING
Trial details
- NCT number
- NCT05877859
- Sponsor
- Emory University
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-05-30
- Primary completion
- 2027-02-20
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.